Skip to main content

Table 8 End of treatment distribution of the study group

From: PET/CT vs CECT in assessment of therapeutic response in lymphoma

  Number Percent
CT
 Complete regression 5 25.0
 Progression disease 6 30.0
 Partial regression 4 20.0
 Stationary disease 5 25.0
PET
 Complete regression 9 45.0
 Progression disease 7 35.0
 Partial regression 3 15.0
 Stationary disease 1 5.0